Andrew George read Natural Sciences at the University of Cambridge, before going to the University of Southampton to do his PhD, developing a vaccine for lymphoma. He was awarded a Beit Memorial Fellowship before moving to the National Institutes of Health, USA, where he used recombinant techniques to make novel antibodies. He then joined the Hammersmith Hospital, which became part of Imperial College London. At Imperial he was Director of the Graduate School and the School of Professional Development.
Andrew was Deputy Vice Chancellor (Education and International) at Brunel University London (2013-2018) and was also responsible for strategic projects, including a new Learning and Teaching Centre and a Enterprise Resource Planning system. He is now Emeritus Professor at Brunel.
Andrew’s research has sought to understand and manipulate the immune system to prevent the rejection of transplanted organs and treat cancer. He has also used mathematical models to understand how the immune system functions.
Andrew has led on the ethical conduct of research, he was Chair of the National Research Ethics Advisors’ Panel (2009-2017) and on the Clinical Trials Expert Advisory Group for the MHRA (2007-2017). He is non-executive director of the Health Research Authority of the NHS.
He is interim Chair of Imperial College Health Partners and director of West London Business and a Governor of Richmond and Hillcroft Adult Community College and the John Hampden Grammar School. He is a Trustee of the Epilepsy Society and a former Trustee of Action Medical Research.
He is a Fellow of the Royal College of Pathologists, The Higher Education Academy, The Royal Society of Arts and The Royal Society of Biology.
Andrew was appointed MBE for his services to research participants and the ethical governance of clinical research in the 2017 New Year Honours.